Bookmark Icon
Print Icon
Email Icon
Physician HeadShot

Shayan Shirazian, MD

Nephrology (Board Certified, Primary Specialty)
Internal Medicine (Board Certified)
Languages: Spanish, Farsi (Persian)
Office Phone: (212) 305-3273


Dr. Shirazian obtained his undergraduate and medical degrees from Brown University and completed his internal medicine residency and nephrology fellowship at Columbia University Medical Center. After completing his training at Columbia, he spent 7 years at NYU-Winthrop Hospital where he was the fellowship program director and the director of nephrology clinical trials before being recruited back to Columbia.  He is a board-certified general internist and nephrologist and is Assistant Professor of Medicine in the Division of Nephrology at Columbia University Medical Center.

Dr. Shirazian's clinical interests include home dialysis modalities, treating co-morbid mood disorders in patients with kidney disease, hypertension management, cancer-related kidney disease and preventing recurrent kidney stones. Dr. Shirazian is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension. He was voted a Top Doctor in the New York Metro Area for 2018 by New York Magazine and Castle Connolly.

Dr. Shayan Shirazian’s research aims to test, and implement interventions to improve quality of life and self-care in patients with chronic kidney disease (CKD) and end stage renal disease. His research also aims to define the role of comorbid mood disorders in CKD progression. He is currently the Principal Investigator for a funded trial (Coplon grant) of a behavioral-education intervention to improve quality of life in hemodialysis patients. His other research interests include preventing recurrent kidney stones and testing new treatments for cancer-related kidney diseases. You can see a full list of his publications at:

Area of Expertise

Please contact the doctor's office to verify that your insurance is accepted.

Aetna [EPO, HMO, Medicare Managed Care, NY Signature, NYP Employee Plan, POS, PPO, Signature Administrators, Student Health]

Affinity [Essential Plan, Medicaid Managed Care]

Amida Care [Special Needs Plan]

Cigna [EPO, Great West, HMO, POS, PPO]

Emblem/GHI [Medicare Managed Care, PPO]

Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]

Empire Blue Cross Blue Shield [Blue Access (Exchange), EPO, Gatekeeper (Exchange), HMO, Medicare Managed Care, Pathway (Exchange), POS, PPO]

Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]

Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]

Healthfirst [Child/Family Health Plus, Leaf (Exchange), Medicaid Managed Care, Medicare Managed Care]

Local 1199 [Local 1199]

MagnaCare [MagnaCare]

Multiplan [Multiplan]

Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]


UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), Essential Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]

VNSNY CHOICE [Medicare Managed Care, SelectHealth]

WellCare [Medicaid Managed Care, Medicare Managed Care]


Brown University Medical School

Internship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center

Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center


CUMC/Presbyterian Hospital and Vanderbilt Clinic

622 West 168th Street
New York, NY 10032

Phone: (212) 305-3273

Get Directions

Assistant Professor of Medicine at CUMC

Top Doctors New York Metro Area: 2018 
New York Magazine: Top Doctors 2018 
Castle Connolly Regional Top Doctor: 2018 to present

Transit Advisory Notice

Starting Jan. 5, 2019, 1 trains will bypass the 168th Street subway station at NewYork-Presbyterian/Columbia University Irving Medical Center until early 2020.